Dyne Therapeutics

Principal Scientist, Toxicology

Dyne Therapeutics$159K — $195K *
Pharmaceuticals & Biotech
8 - 10 years of experience
Job Overview by Ladders

Qualifications

  • PhD or equivalent experience in a scientific discipline with 8+ years of relevant experience.
  • Preferred board certification related to toxicology.
  • Expertise in nonclinical safety assessment and leadership in diverse development programs.
  • Skilled in designing and managing nonclinical toxicology studies, particularly with contract research organizations (CROs).
  • Strong knowledge of regulatory requirements for nonclinical safety and study compliance.
  • Proficient in interpreting toxicology data and writing high-quality regulatory documents.
  • Ability to address nonclinical safety risks in complex development environments.

Responsibilities

  • Represent toxicology on program teams throughout discovery and development.
  • Design and implement nonclinical safety plans for therapeutic candidates.
  • Act as primary contact for external CROs, ensuring compliance with quality and regulatory standards.
  • Analyze toxicology data and communicate findings to program teams and management.
  • Draft submission-ready documents and toxicology content for regulatory submissions.
  • Lead initiatives to resolve issues in investigative and discovery toxicology.

Benefits

  • Collaborative work environment fostering creativity and innovation.
  • Opportunity to influence drug development from discovery to clinical trials.
  • Access to cutting-edge research in antibody oligonucleotide therapeutics.
  • Engagement with regulatory authorities, enhancing professional visibility.
  • Potential for professional growth through participation in diverse projects.
Full Job Description
Role Summary:

The Principal Scientist, Toxicology is a key member of preclinical development teams and is responsible for the strategic planning and execution of nonclinical safety plans for Dyne's portfolio programs, supporting late discovery through first-in-human and proof-of-concept clinical studies of investigational antibody oligonucleotide therapeutics to treat serious muscle diseases. The role applies an in-depth understanding of regulatory guidance related to nonclinical development and designs, oversees, and critically evaluates exploratory and GLP-compliant toxicology studies. The Principal Scientist authors and reviews nonclinical regulatory documents and participates in interactions with regulatory authorities.

This is a full-time position based in Waltham, MA

Primary Responsibilities:
  • Represent toxicology on program teams, providing expertise and guidance from discovery through development.
  • Design and execute nonclinical safety plans for Dyne candidate therapeutics.
  • Serve as the principal contact to external CROs executing these studies, ensuring studies are conducted in line with the appropriate quality and regulatory standards and guidelines (FDA, CHMP, WHO and GLP).
  • Interpret toxicology data and communicate results to program teams and senior management.
  • Write submission-ready documentation and appropriate toxicology content of regulatory submissions.
  • Lead issue-resolution teams, driving the science for investigative and discovery toxicology as needed.

Education and Skills Requirements:
  • PhD or equivalent experience in a scientific discipline and a minimum of 8+ years related experience.
  • Relevant board certification preferred.
  • Demonstrated expertise in nonclinical safety assessment and the ability to provide scientific leadership across development programs.
  • Experience designing, managing, and overseeing nonclinical toxicology studies, including work conducted at contract research organizations.
  • Strong understanding of regulatory requirements governing nonclinical safety, with experience ensuring compliant study execution and documentation.
  • Proven ability to interpret and critically evaluate toxicology data and author or review high-quality study reports and regulatory documentation.
  • Ability to anticipate, assess, and address nonclinical safety and regulatory risks in complex development environments.
  • Experience applying or advancing toxicological methods, technologies, or approaches.
  • Experience assessing toxicity of antibody-drug conjugates and or oligonucleotide-based therapeutics is a plus.
  • Expertise in immunology or immunotoxicology is a plus.
  • Excellent written and verbal communication skills, with the ability to communicate complex scientific concepts to cross-functional stakeholders.
  • Demonstrated ability to work effectively in a collaborative, fast-paced environment while managing multiple priorities and timelines.

#LI-Onsite

MA Pay Range

$159,000-$195,000 USD

The pay range reflects the base pay range Dyne reasonably expects to pay for this role at the time of posting. Individual compensation depends on factors such as education, experience, job-related knowledge, and demonstrated skills.

The statements contained herein reflect general details as necessary to describe the principles functions for this job, the level of knowledge and skill typically required, and the scope of responsibility, but should not be considered an all-inclusive listing of work requirements. Individuals may perform other duties as assigned, including work in other functional areas to cover absences or relief, to equalize peak work periods or otherwise balance workload.

About Dyne Therapeutics

Dyne Therapeutics is a biotechnology company that is focused on developing therapies for patients with genetically driven muscle diseases. The company is developing a platform that is designed to deliver nucleic acids to muscle tissue. Dyne's lead product candidate is DYN101, which is a treatment for patients with myotonic dystrophy type 1 (DM1). DM1 is a genetic disorder that affects the muscles and other body systems. DYN101 is designed to reduce the levels of toxic RNA that are produced by the mutated gene that causes DM1. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Learn more about Dyne Therapeutics
Size
70 employees
Market Cap
$633.4 million
Industry
NASDAQ

Similar Jobs

More Jobs at Dyne Therapeutics

More Pharmaceuticals & Biotech Jobs

Find similar Principal Scientist, Toxicology jobs: